Pfizer -with- King (Animal health products in the State) [2010] IECompA M10037 (29 October 2010)

Pfizer -with- King (Animal health products in the State) [2010] IECompA M10037 (29 October 2010)

The Competition Authority determined that the proposed acquisition would not substantially lessen competition in the market for animal health products in the State.

Citation
[2010] IECompA M10037
Parties
Acquirer: Pfizer Incorporated; Target: King Pharmaceuticals Incorporated
Jurisdiction
Ireland
Judgment Date
29 October 2010
Procedural Posture
Merger Notification / Phase 1 Clearance
Outcome
Cleared
Legal Topics
Merger Control, Acquisition, Animal Health Products
Competition Law Merger Control Acquisition Animal Health Products

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Pfizer Incorporated

Acquirer

King Pharmaceuticals Incorporated

Target

Procedural Posture

Merger Notification / Phase 1 Clearance

Legal Issues

  1. 1 Whether the proposed acquisition of King Pharmaceuticals by Pfizer would substantially lessen competition in the market for animal health products in the State

Ratio Decidendi

The Competition Authority determined that the proposed acquisition would not substantially lessen competition in the market for animal health products in the State.

Court Disposition

Cleared

Orders

  • The proposed acquisition of King Pharmaceuticals Incorporated by Pfizer Incorporated is cleared.